Abstract:Recent genomics and epigenetic advances have empowered the exploration of DNA/RNA methylation and histone modifications crucial for gene expression in response to stress, aging and disease. Interest in understanding neuronal plasticity's epigenetic mechanisms, influencing brain rewiring amid development, aging and neurodegenerative disorders, continues to grow. Histone acetylation dysregulation, a commonality in diverse brain disorders, has become a therapeutic focus. Histone acetyltransferases and histone deacetylases have emerged as promising targets for neurodegenerative disorder treatment. This review delves into histone acetylation regulation, potential therapies and future perspectives for disorders like Alzheimer's, Parkinson's and Huntington's. Exploring genetic–environmental interplay through models and studies reveals molecular changes, behavioral insights and early intervention possibilities targeting the epigenome in at-risk individuals. Scientists have made progress in understanding how our genes and their chemical modifications play a role in how our brains respond to stress, age and diseases. They are particularly interested in how these processes affect the flexibility of our brain circuits, which is important during growth and aging and in conditions like Alzheimer's and Parkinson's. One key area of focus is controlling a specific chemical change called histone acetylation, which tends to go awry in various brain disorders. Researchers are looking at potential treatments that target specific proteins related to this process. This review explores how these chemical changes might be regulated, potential treatments and the future for disorders like Alzheimer's, Parkinson's and Huntington's. By studying the interaction between our genes and the environment, scientists are uncovering changes at the molecular level, gaining insights into behavior and exploring ways to intervene early for people who are at risk. Unraveling the brain's epigenetic dance: histone acetylation changes play a key role in Alzheimer's, Parkinson's and Huntington's. Explores potential therapeutic avenues and insights into early interventions. #Epigenetics #Neuroscience.

Epigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression

Epigenetic Modulation: Research Progress on Histone Acetylation Levels in Major Depressive Disorders

Upregulation of HDAC9 in Hippocampal Neurons Mediates Depression-Like Behaviours by Inhibiting ANXA2 Degradation

Involvement of 5-HT1A Receptor-Mediated Histone Acetylation in the Regulation of Depression.

Targeting histone deacetylases: Emerging applications beyond cancer

Effects of Histone Modification in Major Depressive Disorder

Antidepressant Effect of the Novel Histone Deacetylase-5 Inhibitor T2943 in a Chronic Restraint Stress Mouse Model

Histone Deacetylases as Epigenetic Targets for Treating Parkinson's Disease

Histone Deacetylases and Their Inhibitors: Molecular Mechanisms and Therapeutic Implications in Diabetes Mellitus

Histone Deacetylases in Modulating Cardiac Disease and Their Clinical Translational and Therapeutic Implications

Deciphering Depression: Epigenetic Mechanisms and Treatment Strategies

Technologies of Targeting Histone Deacetylase in Drug Discovery: Current Progress and Emerging Prospects.

Perspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases

Role of histone deacetylases and their inhibitors in neurological diseases

The Development Prospection of HDAC Inhibitors As a Potential Therapeutic Direction in Alzheimer’s Disease

Depressive-Like Behaviors Induced by Chronic Social Defeat Stress Are Associated With HDAC7 Reduction in the Nucleus Accumbens

Strategies in Developing Promising Histone Deacetylase Inhibitors.

Restoring the epigenome in Alzheimer's disease: Advancing HDAC inhibitors as therapeutic agents

The Development Prospection of HDAC Inhibitors As a Potential Therapeutic Direction in Alzheimer's Disease.

Advances in the Application of Histone Deacetylase Inhibitors in Eye Disease

Unlocking the epigenetic symphony: histone acetylation's impact on neurobehavioral change in neurodegenerative disorders